Featured Research

from universities, journals, and other organizations

Elucidating side effects of antineoplastic agent

Date:
October 5, 2010
Source:
CNRS (Délégation Paris Michel-Ange)
Summary:
Cisplatin, an anticancer drug widely used for treating various types of tumor, can induce side effects in the short term. A team of scientists has provided first in vitro evidence that this antitumor agent modifies the sensitivity of cellular pressure sensors. This completely novel mechanism could help to elucidate certain neurological side effects of cisplatin hitherto unexplained. These results could open potential avenues for improving the chemotherapeutic efficacy of cisplatin-based compounds. The researchers now plan to test them on animal models.

Cisplatin, an anticancer drug widely used for treating various types of tumor, can induce side effects in the short term. A team of scientists, mostly from CNRS and the Université de Nice, has provided first in vitro evidence that this antitumor agent modifies the sensitivity of cellular pressure sensors. This completely novel mechanism could help to elucidate certain neurological side effects of cisplatin hitherto unexplained. These results could open potential avenues for improving the chemotherapeutic efficacy of cisplatin-based compounds. The researchers now plan to test them on animal models.

Their work was published October 1, 2010 in the journal Cancer Research.

Cisplatin is a platinum-based molecule widely used in the treatment of various forms of cancer in humans. Following intravenous administration, it penetrates the cells to form stable complexes with the DNA molecule, thereby preferentially killing tumor cells, which are the most vulnerable. In order to proliferate, cancer cells actually need to constantly replicate their DNA, which they can no longer do when it is complexed with cisplatin. However, this treatment has a major drawback. Within an hour or even half an hour following injection, some patients suffer from side effects: perception and hearing disorders, tinnitus and sometimes inner ear dysfunctions causing dizziness. The unpleasantness of these neurological effects can prompt patients to interrupt the treatment, despite its efficacy. A better understanding of these short-term side effects is therefore crucial.

Most research laboratories mainly focus on cisplatin's action on DNA. However, such genotoxic effects cannot occur very rapidly: consequently, they do not explain the short-term side effects of cisplatin and other antineoplastic drugs of the same family. For this reason, the team of scientists headed by Laurent Counillon and Mallorie Poët, researchers at the Institut de Pharmacologie Moléculaire et Cellulaire (CNRS/Université de Nice) decided to focus on another aspect of cisplatin: its already known action at the cell membrane level.

The researchers conducted their experiments in a model cell system. They discovered that cisplatin, independently of its action on DNA, is capable of modifying, within a few minutes, the architecture of a cell membrane: injecting this molecule into a cell changes the shape, morphology and tension of its membrane. Yet, the cell membrane contains numerous pressure- and stretch-sensitive proteins. These sensors regulate the pain threshold in peripheral nerve fibers and detect sound waves and "verticality" in the vestibular system of the ear . Pursuing their investigations, the scientists managed to demonstrate that cisplatin disrupts the functioning of these mechanosensitive sensors, which may trigger neurological effects. They have identified and described a novel mechanism through which this antitumor agent acts. This process could therefore explain the occurrence of cisplatin's short-term side effects.

These results make it possible to envisage optimizing the efficacy of platinum-based anticancer treatments by combining them with compounds that reduce these short-term side effects. Researchers are now due to proceed with animal testing.

Other contributors include the Laboratoire "Adhésion et Inflammation" (Inserm/CNRS/Université Aix-Marseille 2), the Centre Commun de Microscopie Appliquée de l'Université de Nice and a team from the Université de Rennes 1.


Story Source:

The above story is based on materials provided by CNRS (Délégation Paris Michel-Ange). Note: Materials may be edited for content and length.


Journal Reference:

  1. N. Milosavljevic, C. Duranton, N. Djerbi, P. H. Puech, P. Gounon, D. Lagadic-Gossmann, M. T. Dimanche-Boitrel, C. Rauch, M. Tauc, L. Counillon, M. Poet. Nongenomic Effects of Cisplatin: Acute Inhibition of Mechanosensitive Transporters and Channels without Actin Remodeling. Cancer Research, 2010; 70 (19): 7514 DOI: 10.1158/0008-5472.CAN-10-1253

Cite This Page:

CNRS (Délégation Paris Michel-Ange). "Elucidating side effects of antineoplastic agent." ScienceDaily. ScienceDaily, 5 October 2010. <www.sciencedaily.com/releases/2010/10/101005141117.htm>.
CNRS (Délégation Paris Michel-Ange). (2010, October 5). Elucidating side effects of antineoplastic agent. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2010/10/101005141117.htm
CNRS (Délégation Paris Michel-Ange). "Elucidating side effects of antineoplastic agent." ScienceDaily. www.sciencedaily.com/releases/2010/10/101005141117.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Cases Keep Coming for Monrovia's Island Hospital

Ebola Cases Keep Coming for Monrovia's Island Hospital

AFP (Oct. 1, 2014) — A look inside Monrovia's Island Hospital, a key treatment centre in the fight against Ebola in Liberia's capital city. Duration: 00:34 Video provided by AFP
Powered by NewsLook.com
Ebola Puts Stress on Liberian Health Workers

Ebola Puts Stress on Liberian Health Workers

AP (Oct. 1, 2014) — The Ebola outbreak is putting stress on first responders in Liberia. Ambulance drivers say they are struggling with chronic shortages of safety equipment and patients who don't want to go to the hospital. (Oct. 1) Video provided by AP
Powered by NewsLook.com
Doctors Reassure Public Ebola Patient Won't Cause Outbreak

Doctors Reassure Public Ebola Patient Won't Cause Outbreak

Newsy (Sep. 30, 2014) — After the announcement that the first U.S. patient had been diagnosed with Ebola, doctors were quick to say a U.S. outbreak is highly unlikely. Video provided by Newsy
Powered by NewsLook.com
TX Hospital Confirms Patient Admitted With Ebola

TX Hospital Confirms Patient Admitted With Ebola

AP (Sep. 30, 2014) — Medical officials from Texas Health Presbyterian Hospital confirm they are treating a patient with the Ebola virus, the first case found in the US. (Sept. 30 Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins